Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PALIPERIDONE Cause Product dose omission issue? 1,304 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 1,304 reports of Product dose omission issue have been filed in association with PALIPERIDONE (paliperidone). This represents 3.2% of all adverse event reports for PALIPERIDONE.

1,304
Reports of Product dose omission issue with PALIPERIDONE
3.2%
of all PALIPERIDONE reports
8
Deaths
218
Hospitalizations

How Dangerous Is Product dose omission issue From PALIPERIDONE?

Of the 1,304 reports, 8 (0.6%) resulted in death, 218 (16.7%) required hospitalization, and 4 (0.3%) were considered life-threatening.

Is Product dose omission issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PALIPERIDONE. However, 1,304 reports have been filed with the FAERS database.

What Other Side Effects Does PALIPERIDONE Cause?

Injury (4,348) Gynaecomastia (4,155) Off label use (4,041) Drug ineffective (2,812) Weight increased (2,136) Hospitalisation (2,066) Abnormal weight gain (1,816) Hyperprolactinaemia (1,427) Schizophrenia (1,361) Galactorrhoea (1,277)

What Other Drugs Cause Product dose omission issue?

DUPILUMAB (18,189) USTEKINUMAB (9,405) GUSELKUMAB (9,267) LENALIDOMIDE (8,145) MEPOLIZUMAB (5,873) TOFACITINIB (5,646) VOXELOTOR (5,122) BELIMUMAB (4,671) SECUKINUMAB (4,572) APREMILAST (4,460)

Which PALIPERIDONE Alternatives Have Lower Product dose omission issue Risk?

PALIPERIDONE vs PALIVIZUMAB PALIPERIDONE vs PALONOSETRON PALIPERIDONE vs PAMIDRONATE PALIPERIDONE vs PAMIDRONIC ACID PALIPERIDONE vs PANCRELIPASE

Related Pages

PALIPERIDONE Full Profile All Product dose omission issue Reports All Drugs Causing Product dose omission issue PALIPERIDONE Demographics